These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 764997

  • 41. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 42. [Simultaneous administration at different dosages of attenuated live virus vaccines against measles, mumps and rubella].
    Ramos-Alvarez M, Bessudo L, Kenny MT, Jackson JE, Schwarz AJ.
    Bol Med Hosp Infant Mex; 1976 Jun 28; 33(4):875-86. PubMed ID: 782484
    [No Abstract] [Full Text] [Related]

  • 43. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA.
    Ann Ig; 2002 Jun 28; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract] [Full Text] [Related]

  • 44. Measles/mumps/rubella vaccine.
    Lancet; 1988 Oct 08; 2(8615):860. PubMed ID: 2902310
    [No Abstract] [Full Text] [Related]

  • 45. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE, Buynak EB, Stokes J, Hilleman MR.
    Pediatrics; 1973 Mar 08; 51(3):467-75. PubMed ID: 4707864
    [No Abstract] [Full Text] [Related]

  • 46. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M, Berger R, Glück R, Wegmann A.
    Dev Biol Stand; 1986 Mar 08; 65():25-7. PubMed ID: 3549399
    [Abstract] [Full Text] [Related]

  • 47. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep 04; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract] [Full Text] [Related]

  • 48. [Rubella, measles, mumps--epidemiologic, occupational medicine significance and efficacy of adult vaccination].
    Hofmann F, Sydow B.
    Offentl Gesundheitswes; 1989 Jun 04; 51(6):299-302. PubMed ID: 2526940
    [Abstract] [Full Text] [Related]

  • 49. MMR vaccine--one year on.
    Walker D.
    Practitioner; 1990 May 22; 234(1489):550-2. PubMed ID: 2392406
    [No Abstract] [Full Text] [Related]

  • 50. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA, Novelli VM, Lipton SV, Pollock B.
    Pediatrics; 1988 Jun 22; 81(6):779-84. PubMed ID: 2835743
    [Abstract] [Full Text] [Related]

  • 51. Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?
    Fahlgren K.
    Scand J Soc Med; 1988 Jun 22; 16(3):129-35. PubMed ID: 3057621
    [Abstract] [Full Text] [Related]

  • 52. The impact of MMR vaccine on mumps infection in England and Wales.
    Jones AG, White JM, Begg NT.
    CDR (Lond Engl Rev); 1991 Aug 16; 1(9):R93-6. PubMed ID: 1669792
    [Abstract] [Full Text] [Related]

  • 53. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
    Stokes J, Weibel RE, Villarejos VM, Arguedas JA, Buynak EB, Hilleman MR.
    JAMA; 1971 Oct 04; 218(1):57-61. PubMed ID: 4937795
    [No Abstract] [Full Text] [Related]

  • 54. Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine.
    Berger R, Just M, Glück R.
    J Biol Stand; 1988 Oct 04; 16(4):269-73. PubMed ID: 3198657
    [Abstract] [Full Text] [Related]

  • 55. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul 26; 6(30):259. PubMed ID: 8755703
    [No Abstract] [Full Text] [Related]

  • 56. MMR vaccine coverage at 24 months stabilises in the UK.
    Commun Dis Rep CDR Wkly; 1999 Mar 26; 9(13):113, 116. PubMed ID: 10230112
    [No Abstract] [Full Text] [Related]

  • 57. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV, Iuminova NV.
    Vopr Virusol; 2004 Mar 26; 49(3):8-11. PubMed ID: 15188648
    [Abstract] [Full Text] [Related]

  • 58. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS, Stracener CE, Bass JW.
    JAMA; 1991 Apr 24; 265(16):2095-6. PubMed ID: 2013930
    [Abstract] [Full Text] [Related]

  • 59. [Elimination of measles, mumps and rubella in Switzerland].
    Herzog C.
    Soz Praventivmed; 1986 Apr 24; 31(6):326-9. PubMed ID: 3811611
    [Abstract] [Full Text] [Related]

  • 60. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
    Wellington K, Goa KL.
    Drugs; 2003 Apr 24; 63(19):2107-26. PubMed ID: 12962524
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.